David K. Wallace, MD

David K. Wallace, MD, MPH, is the Marilyn K. Glick Professor and Chair of the Department of Ophthalmology at the Indiana University School of Medicine, and he serves as Director of the Eugene and Marilyn Glick Eye Institute. He received his undergraduate and medical degrees from Indiana University and completed his Ophthalmology Residency as Chief Resident at the Baylor College of Medicine in Houston, Texas. He obtained a Masters in Public Health in Epidemiology at the University of North Carolina. After 10 years on the faculty at UNC, including 6 years as residency program director, he joined the Duke University Department of Ophthalmology in 2005. While at Duke, he was promoted to Professor of Ophthalmology and Pediatrics, Vice-Chair for Clinical Strategic Planning, and Director of Clinical Research. He has served as Senior Associate Editor for the Journal of the American Association of Pediatric Ophthalmology and Strabismus and as President of the North Carolina Society of Eye Physicians and Surgeons. In 2017, he returned to the Indiana University School of Medicine to lead the Department of Ophthalmology. Dr. Wallace's primary research interests are retinopathy of prematurity, amblyopia, and clinical trials in pediatric ophthalmology. He served a 5-year term as chair of an NIH-funded research network, the Pediatric Eye Disease Investigator Group (PEDIG). He has served as protocol chair for several PEDIG studies, including a phase 1 dose de-escalation study of intravitreous bevacizumab for retinopathy of prematurity. He currently leads a PEDIG multi-center randomized trial of low-dose bevacizumab versus laser, and a second trial comparing two doses of bevacizumab. He serves on the Board of Directors and as Secretary for Program for the American Association of Pediatric Ophthalmology and Strabismus (AAPOS), and he chairs the pediatric section of American Academy of Ophthalmology's Preferred Practice Patterns.